Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease

BACKGROUND AND OBJECTIVES: The safety of inflammatory bowel disease medications during lactation is of significant relevance to women of childbearing potential. Available data regarding the transfer of biologic agents for inflammatory bowel disease via breast milk are limited to case reports. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wan, Fennimore, Blair, Beaulieu, Dawn B., Arsenescu, Razvan, Stein, Adam C., Chen, Jingjing, Lin, Tiffany, McKnight, Sonya, Kadali, Harisha, Rosario, Maria, Lirio, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195772/
https://www.ncbi.nlm.nih.gov/pubmed/33544318
http://dx.doi.org/10.1007/s40262-021-00985-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195772/
https://www.ncbi.nlm.nih.gov/pubmed/33544318
http://dx.doi.org/10.1007/s40262-021-00985-4

Ejemplares similares